Multicenter Study of Cultured Autologous Oral Mucosal Epithelial Cell-Sheet (CAOMECS) Transplantation to Patients With Total Limbal Stem Cell Deficiency

Trial Profile

Multicenter Study of Cultured Autologous Oral Mucosal Epithelial Cell-Sheet (CAOMECS) Transplantation to Patients With Total Limbal Stem Cell Deficiency

Recruiting
Phase of Trial: Phase III

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Mucosal-derived epithelial cell therapy (Primary)
  • Indications Limbal stem cell deficiency
  • Focus Therapeutic Use
  • Sponsors CellSeed
  • Most Recent Events

    • 19 Apr 2017 This trial has been discontinued in Austria (End date:2014-08-08) as per European Clinical Trials Database record.
    • 24 Mar 2015 Status changed from not yet recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
    • 27 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top